Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

Gestational diabetes mellitus (GDM) is a pervasive metabolic disorder associated with a spectrum of long-term adverse ...

Semaglutide, the active ingredient in the diabetes and weight loss drugs Ozempic and Wegovy, could lower the risk for ...

"These results provide reassurance and can assist clinicians in making informed treatment decisions when selecting metformin ...

On Monday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the SOUL Phase 3 cardiovascular outcomes trial.

USA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing ...

Some 61 million people live with diabetes in Europe, of whom about 90% have type 2 diabetes (T2D) [1], in which the body may ...

Potential fathers with type 2 diabetes can be reassured that taking the drug metformin is not associated with birth defects in their offspring, concludes a large study of more than 3 million ...

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

As global populations age, the prevalence of type 2 diabetes and its associated complications, such as sarcopenia, continues to rise.

The findings, based on more than 3 million pregnancies and published by The BMJ, showed that metformin can continue to be ...